In 2018 I shared a message on advocacy as physicians. As the depth of #StructuralRacism in our country is further revealed by the devastating loss of #GeorgeFloyd and disparities within #COVID19, I challenge you to stand up for your community #MedTwitter https://t.co/XsprMMH9xw
Good morning from Hollywood, FL. At 65F this is the best time of year! We are hiring by the way! If you do GI, NET or head and neck (and others) let me know @SylvesterCancer@univmiami@ASCO@uicc@myESMO@IASLC
@KoheiShitara@singhv2003 Agree, to aim for some systemic control first, especially since locally advanced already presents the challenge of being larger and/or with nodal involvement
Pleased to share our ongoing phase II TNT protocol (FLOT, pembro, short RT) for resectable GEJ adenocarcinoma, integrating whole-genome ctDNA to support clinical CR-based organ preservation https://t.co/zeLV0S5VQl @myESMO@oncodaily@OncoAlert
Are you an oncology attending—anywhere in the world? 🌍
Join The Hidden Struggle Study exploring anxiety, depression & burnout among oncology physicians.
🧠 Fill a short survey & make your voice count.
DM or email [email protected] for the form.
#PhysicianWellbeing
Pleased to share our experience of zolbetuximab induced gastritis @myESMO@ESMO_Open More anorexia & albumin decline in diffuse gastritis, yet reversible without discontinuation. Careful differentiation with gastritis vs disease progression needed. https://t.co/OBoIU3HZNE
We have an unexpected opening in our gastrointestinal pathology fellowship for 2026-2027 at the University of Miami.
If you are interested, please contact [email protected] - include your CV!
Pleased to report FGFR2b expression in gastric cancer and relationship with other biomarkers @ESMO_Open@myESMO. The results of bemarituzumab phase 3 studies are awaited.@OncoAlert@oncodaily
https://t.co/wmaLAJPq8q
Our very own Dr. Peter Hosein (@PeterHoseinMD) presented "Is Pancreas Subtyping Ready for Prime Time?" at #ASCO25 in a panel discussion focused on #PancreaticCancer research findings. Learn more about our presence: https://t.co/toCWJXvq47.